Compounded Semaglutide vs. Wegovy Self-Pay: Which Saves You More in 2026?

You have narrowed your decision down to two options: branded Wegovy (self-pay) or compounded semaglutide through telehealth. Both deliver the same active molecule — semaglutide. Both require a prescription from a licensed clinician. But the cost, convenience, and regulatory protections differ significantly. This guide provides a transparent, side-by-side comparison so you can make the right choice for your situation.

The Complete Comparison

When Wegovy Self-Pay Makes Sense

• You prioritize FDA approval: Wegovy has undergone full FDA manufacturing review, clinical trials (STEP program), and post-market surveillance. This provides the highest regulatory assurance.
• You want pen convenience: Pre-filled pens are simpler to use — no drawing from vials, no measuring doses.
• You can afford the premium: At $6,000–$16,200/year, Wegovy self-pay is a significant financial commitment.
• Your insurance may eventually cover it: Having an established Wegovy prescription can streamline a future insurance prior authorization.

When Compounded Semaglutide Makes Sense

• Cost is a primary factor: At $1,800–$4,788/year, compounded semaglutide saves $4,200–$11,400 annually compared to Wegovy self-pay.
• Wegovy is out of stock: Branded GLP-1 shortages have been chronic since 2023. Compounded pharmacies maintain dedicated inventory.
• You want dose flexibility: Compounded semaglutide can be prepared at custom concentrations, enabling more granular dose titration.
• You prefer direct-to-door delivery: No pharmacy lines, no stock issues, no insurance paperwork.

For a deeper dive into compounded medication safety, read our compounded semaglutide safety guide and understand the current FDA regulatory landscape. For cost optimization strategies, see our cost without insurance guide and HSA/FSA payment guide.

The 12-Month Cost Breakdown

Here is what each pathway costs over a full year of treatment at maintenance dose:

At the most optimized level (compounded semaglutide + HSA/FSA tax savings), you can access GLP-1 therapy for as little as $1,624/year — a 90% reduction from Wegovy list price.

Frequently Asked Questions

Is compounded semaglutide as effective as Wegovy?

When sourced from a licensed 503A pharmacy using pure semaglutide base at equivalent doses, the clinical effect is the same — they are the same molecule. The difference is manufacturing oversight, not molecular chemistry.

Why is compounded so much cheaper?

Branded Wegovy's price includes Novo Nordisk's R&D recovery, FDA approval costs, marketing budget, and profit margin. Compounded semaglutide uses the same active ingredient but bypasses brand-name markups while still requiring legitimate pharmacy licensing and clinician oversight.

Can I switch from Wegovy to compounded?

Yes. Your new clinician will prescribe compounded semaglutide at your current established dose. No re-titration needed. See our provider switching guide for a seamless transition process.